Invention Grant
- Patent Title: Formulation of human antibodies for treating TNF-alpha associated disorders
-
Application No.: US15418460Application Date: 2017-01-27
-
Publication No.: US09750808B2Publication Date: 2017-09-05
- Inventor: Hans-Juergen Krause , Lisa Baust , Michael Dickes
- Applicant: AbbVie Biotechnology Ltd
- Applicant Address: BM Hamilton
- Assignee: ABBVIE BIOTECHNOLOGY LTD.
- Current Assignee: ABBVIE BIOTECHNOLOGY LTD.
- Current Assignee Address: BM Hamilton
- Agency: Ropes & Gray LLP
- Agent James F. Haley, Jr.; Brian M. Gummow
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/22 ; C07K16/24 ; A61K47/26 ; C07K14/525
Abstract:
A liquid aqueous pharmaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.
Public/Granted literature
- US20170151329A1 FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS Public/Granted day:2017-06-01
Information query
